Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease

CRISPR in Sickle Cell: Transforming Care Through Gene Editing

Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers

Curative Strategies for Sickle Cell Disease: The Future of Gene Editing

Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role

Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care

Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning

Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma

Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study

Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers

Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer

CAR T in Marginal Zone Lymphoma: Insights from the TRANSCEND FL Study

CAR T and Bispecifics in LBCL: Redefining Second-Line Therapy Choices

Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing

The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption

From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care

Expanding Cancer Detection: How MCED Testing Complements Standard Screening

Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening

Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing

Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay